Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-blinded Sham-controlled Crossover Trial to Evaluate the Effect of Immunoadsorption on Post-Corona Virus Disease (COVID)-Syndrome

NCT05841498 is registered in ClinicalTrials.gov with University Medical Center Mainz as lead sponsor.

NCT NCT05841498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05841498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-blinded Sham-controlled Crossover Trial to Evaluate the Effect of Immunoadsorption on Post-Corona Virus Disease (COVID)-Syndrome
Lead sponsor
University Medical Center Mainz
Phase
Not applicable
Overall status
Completed
Start date
May 8, 2023
Completion date
May 12, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post covid-19 condition, post-covid syndrome, post-covid-19 syndrome